🔎 Trials Near Me

Home › Major Depressive Disorder › Texas › Houston

Major Depressive Disorder clinical trials in Houston, TX

16 studies for Major Depressive Disorder are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

RecruitingPhase 3
  • Baylor College of Medicine, Houston
  • Houston Clinical Trials LLC, Bellaire · 7 mi away
Ages 18 to 74 · All sexes · Updated Sep 25, 2026 · NCT06559306

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

RecruitingPhase 3
  • DM Clinical Research, Houston
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT05850689

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

RecruitingPhase 3
  • John S Dunn Behavioral Sciences Center at UTHealth Houston, Houston
Ages 12 to 17 · All sexes · Updated Sep 25, 2026 · NCT07227454

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

RecruitingPhase 3
  • Brain Health Consultants and TMS Center, Houston
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06793397

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

RecruitingPhase 3
  • Vanda Investigational Site, Houston
Ages 18 to 65 · All sexes · Updated Sep 24, 2026 · NCT06830044

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

RecruitingPhase 1Healthy volunteers welcome
  • Wells Medicine, Houston
  • Texas A&M (Houston Methodist Hospital Location), Houston
Ages 21 to 45 · All sexes · Updated Sep 15, 2026 · NCT06480201

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

RecruitingPhase 2
  • Baylor College of Medicine, Houston
Ages 18 to 65 · All sexes · Updated Sep 14, 2026 · NCT07284667

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Recruiting
  • CHI St. Luke's Health Baylor College of Medicine Med. Ctr, Houston
  • The Methodist Hospital, Houston
Ages 22 to 70 · All sexes · Updated Aug 28, 2026 · NCT06423430

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

RecruitingPhase 2
  • Elevate Synapsis, LLC, Atascocita · 20 mi away
  • Synapsis Bio, Atascocita · 20 mi away
Ages 18 to 64 · All sexes · Updated Jul 27, 2026 · NCT07115329

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RecruitingPhase 3
  • Neurocrine Clinical Site, Bellaire · 7 mi away
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RecruitingPhase 3
  • Neurocrine Clinical Site, Houston
  • Neurocrine Clinical Site, Bellaire · 7 mi away
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT06966401

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

RecruitingPhase 3
  • Clinical Research Site, Houston
  • Clinical Research Site, Bellaire · 7 mi away
Ages 18 to 65 · All sexes · Updated Jul 24, 2026 · NCT07484217

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

RecruitingPhase 2
  • Houston Clinical Trials - Bellaire /ID# 277551, Bellaire · 7 mi away
Ages 18 to 65 · All sexes · Updated Jun 15, 2026 · NCT07276997

Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia

Recruiting
  • Houston Center For Advanced Psychiatric Treatment, Houston
Ages 22 to 75 · All sexes · Updated May 1, 2026 · NCT06982820

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RecruitingPhase 3
  • Neurocrine Clinical Site, Houston
Ages 18 and older · All sexes · Updated Oct 29, 2025 · NCT06786624

Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder

RecruitingHealthy volunteers welcome
  • Michael E. DeBakey VA Medical Center, Houston
  • The University of Texas health Science Center at Houston, Houston
Ages 18 and older · All sexes · Updated Jan 9, 2025 · NCT06695767

Major Depressive Disorder trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.